Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy?

Marco Racioppi, Emilio Sacco, Pierfrancesco Bassi, Andrea Volpe, Luca Bongiovanni, Daniele D'Agostino, Angelo Totaro, Alessandro D'Addessi, Francesco Marangi, Giuseppe Palermo, Francesco Pinto

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

OBJECTIVES: Non-muscle-invasive bladder cancer is characterized by a high recurrence rate after primary transurethral resection. In case of bacillus Calmette-Guérin-refractory neoplasms, cystectomy is the gold standard. In this study the effects of thermochemotherapy with mitomycin C were evaluated in high-risk bladder cancer nonresponders to previous therapy. PATIENTS AND METHODS: Between January 2006 and December 2009, 30 patients were enrolled with recurrent stage carcinoma in situ, Ta and T1, grade G1 to G3 non-muscle-invasive bladder cancer refractory to chemotherapy or immunotherapy and so becoming suitable for radical cystectomy. All patients underwent endovesical thermochemotherapy: 16 patients underwent a prophylactic scheme and 14 patients underwent an ablative scheme. RESULTS: All the patients completed the study. The mean follow-up for all the patients enrolled was 14 months. Thirteen of 30 patients (43.30%) were disease free and 17 patients (56.70%) had recurrence. In the prophylactic group, 7 of 16 patients (43.75%) were disease free and 9 patients (46.25%) had tumor recurrence; no progression was observed. In the ablative group, 3 patients (17, 64%) had progression to muscle-invasive disease. Side effects were generally mild. CONCLUSIONS: Thermochemotherapy could be considered an additional tool in patients refractory to intravesical therapies before considering early cystectomy.
Original languageEnglish
Pages (from-to)311-318
Number of pages8
JournalUrologia Internationalis
DOIs
Publication statusPublished - 2012

Keywords

  • Bladder cancer
  • thermochemotherapy

Fingerprint

Dive into the research topics of 'Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy?'. Together they form a unique fingerprint.

Cite this